Tag Archives: CureDuchenne

June, 2017

February, 2017

November, 2015

  • 25 November

    FDA Panel Says BioMarin DMD Drug Data Not Persuasive

    SAN RAFAEL, Calif., Nov. 24, 2015 (GLOBE NEWSWIRE) — BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) announced today that the Peripheral and Central Nervous System Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) met to discuss the data submitted to support the New Drug Application (NDA) for KyndrisaTM (drisapersen) for …